Source:http://linkedlifedata.com/resource/pubmed/id/15688235
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2005-5-5
|
pubmed:abstractText |
Local injections of the sclerosing substance Polidocanol has been demonstrated to give good clinical results in a pilot study on patients with chronic Achilles tendinopathy. In this study, 20 consecutive patients (9 men and 11 women, mean age 50 years) with chronic painful mid-portion Achilles tendinopathy were randomised to injection treatment with either Polidocanol (5 mg/ml) (group A) or Lidocaine hydro-chloride (5 mg/ml) + Adrenaline (5 microg/ml) (group B). Both substances have a local anaesthetic effect, but Polidocanol also has a sclerosing effect. The patients and the treating physician were blinded to the substance injected. The short-term effects were evaluated after a maximum of two treatments, 3-6 weeks apart. Before treatment, all patients had structural tendon changes and neo-vascularisation demonstrated with US and colour doppler. Under US and colour doppler-guidance, the injections targeted the area of neo-vascularisation just outside the ventral part of the tendon. For evaluation, the patients recorded the severity of Achilles tendon pain during tendon loading activity, before and after treatment, on a VAS. Patient's satisfaction with treatment was also assessed. At follow-up (mean 3 months) after a maximum of two treatments, 5/10 patients in group A were satisfied with the treatment and had a significantly reduced level of tendon pain (p < 0.005). In group B, no patient was satisfied with treatment. In the pain-free tendons, but not in the painful tendons, neo-vascularisation was absent after treatment. After completion of the study, treatment with Polidocanol injections (Cross-over in group B and additional treatments in group A) resulted in 10/10 and 9/10 satisfied patients in group A and B, respectively. In summary, injections with the sclerosing substance Polidocanol have the potential to reduce tendon pain during activity in patients with chronic painful mid-portion Achilles tendinopathy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anesthetics, Local,
http://linkedlifedata.com/resource/pubmed/chemical/Epinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Lidocaine,
http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols,
http://linkedlifedata.com/resource/pubmed/chemical/Sclerosing Solutions,
http://linkedlifedata.com/resource/pubmed/chemical/polidocanol
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0942-2056
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
338-44
|
pubmed:meshHeading |
pubmed-meshheading:15688235-Achilles Tendon,
pubmed-meshheading:15688235-Anesthetics, Local,
pubmed-meshheading:15688235-Double-Blind Method,
pubmed-meshheading:15688235-Epinephrine,
pubmed-meshheading:15688235-Female,
pubmed-meshheading:15688235-Humans,
pubmed-meshheading:15688235-Lidocaine,
pubmed-meshheading:15688235-Male,
pubmed-meshheading:15688235-Middle Aged,
pubmed-meshheading:15688235-Polyethylene Glycols,
pubmed-meshheading:15688235-Sclerosing Solutions,
pubmed-meshheading:15688235-Sclerotherapy,
pubmed-meshheading:15688235-Statistics, Nonparametric,
pubmed-meshheading:15688235-Tendon Injuries,
pubmed-meshheading:15688235-Treatment Outcome
|
pubmed:year |
2005
|
pubmed:articleTitle |
Sclerosing injections to areas of neo-vascularisation reduce pain in chronic Achilles tendinopathy: a double-blind randomised controlled trial.
|
pubmed:affiliation |
Department of Surgical and Perioperative Science Sports Medicine, Centre for Musculoskeletal Research, National Institute for Working Life, University of Umea, 90187, Umeå, Sweden. hakan.alfredson@idrott.umu.se
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|